The founding team spent the past several years at 10x Genomics, a pioneer in single-cell sequencing technology that could unlock new insights into using actual human antibodies as therapeutics.
The founding team spent the past several years at 10x Genomics, a pioneer in single-cell sequencing technology that could unlock new insights into using actual human antibodies as therapeutics.
